Top Markets
Coin of the day
Canntab Therapeutics Limited Canntab Therapeutics Limited

Canntab Therapeutics Limited

PILL
Rang in Aktien #40577
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Aktienkurs
$0.0036163
Zuletzt synchronisiert: 2023-10-30
Marktkapitalisierung
$118.21K
Veränderung (1 Tag)
0.39%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Canntab Therapeutics Limited (PILL)

Kategorie

Kursverlauf für Canntab Therapeutics Limited (PILL)
Höchster Schlusskurs: $0.00 am 2023-10-01

Niedrigster Schlusskurs: $10.84 am 2011-05-01
Kursverlauf der Aktie von Canntab Therapeutics Limited von 2011 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 -69.79%
2022 -97.70%
2021 -11.16%
2020 81.39%
2019 -54.95%
2018 -81.38%
2017 336.92%
2016 -16.29%
2015 28.89%
2014 -7.77%
2013 -88.89%
2012 -71.13%
2011 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$165.47 27.27%
DE
$36.27 22.59%
JP
$232.21 43.17%
CH
$21.32 13.71%
IN